R Pg Family Wealth Advisory, LLC Repligen Corp Transaction History

R Pg Family Wealth Advisory, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$119.79 - $167.35 $13,656 - $19,077	114 New	114 $16,000
Q2 2022 Aug 12, 2022	SELL	$140.68 - $188.02 $18,851 - $25,194	-134 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$165.87 - $220.95 $4,312 - $5,744	26 Added 24.07%	134 $26,000
Q2 2020 Aug 10, 2020	SELL	$94.33 - $140.48 $4,716 - $7,023	-50 Reduced 31.65%	108 $13,000
Q1 2020 May 14, 2020	SELL	$84.96 - $109.14 $6,032 - $7,748	-71 Reduced 31.0%	158 $15,000
Q4 2019 Feb 12, 2020	BUY	$73.84 - $93.08 $1,329 - $1,675	18 Added 8.53%	229 $21,000
Q1 2019 May 14, 2019	BUY	$49.45 - $62.8 $10,433 - $13,250	211 New	211 $0

486

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.85B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of R Pg Family Wealth Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on R Pg Family Wealth Advisory, LLC with notifications on news.